COVID-19 impact on nuclear medicine: an Australian perspective

First Author: Currie G, Last Author:

"Technegas is in widespread use in Australia and offers a number of clear advantages in the COVID19 patient. The ventilation procedure is faster, reducing time and improving compliance which in turn decreases the risk of room and staff contamination. The apparatus is single use without recirculation and so poses no risk between patients."

Eur J Nucl Med Mol Imaging 2020 Apr 15 : 1–5 [Online ahead of print]